首页 > 最新文献

Cardiovascular Pathology最新文献

英文 中文
Variable regional histomorphology of the ascending aorta: Implications for disease classification 升主动脉的可变区域组织形态:疾病分类的意义
IF 1.9 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-08 DOI: 10.1016/j.carpath.2025.107787
Collin S. Pryma , Md. Shahrier Amin , Charles Leduc , Cecilia Wu , Sarah M. Jenkins , Melanie C. Bois , Joseph J. Maleszewski
Regional differences in the normal histology of the ascending aorta have not been systematically studied, possibly resulting in diagnostic misinterpretation. This study aims to characterize the normal histologic spectrum of the aortic sinus (AS) and tubular aorta (TA) in a normal population. Ascending aortic specimens from 37 autopsy cases (mean age 58.7 years, range 12 to >89 years) without known aortopathy were collected prospectively. Transverse and longitudinal sections from AS and TA were stained with H&E and Verhoeff–Van Gieson. Assessed features included medial and lamellar thickness, lamellar architecture, elastic lamina number, elastic fiber waviness and organization, and features of medial degeneration. Interobserver agreement was assessed using Krippendorff’s alpha. The AS had significantly thinner media and lamellae, more woven lamellar architecture, and greater elastic fiber waviness and non-parallel organization compared to the TA. Elastic lamina number was greater in the posterior TA than AS (p < 0.0001). Pathologist agreement was moderate to satisfactory except for lamellar architecture in the left and posterior AS. No significant differences were observed between the measures with age, sex, or body mass index up to 49 kg/m2. These results provide the first systematic histologic profile of the AS and highlight key differences from the TA—several of which overlap with degenerative changes. Recognizing these normal regional variations is essential to avoid diagnostic overcalls and unnecessary intervention. Accurate specimen labeling, orientation, and sampling are critical in aortic pathology assessment.
升主动脉正常组织学的区域差异尚未系统研究,可能导致诊断误解。本研究的目的是表征正常人群的主动脉窦(AS)和管状主动脉(TA)的正常组织学谱。前瞻性地收集了37例无已知主动脉病变的尸检病例的升主动脉标本(平均年龄58.7岁,范围12 ~ 89岁)。AS和TA的横切面和纵切面用H&;E和verhoefff - van Gieson染色。评估特征包括内侧和板层厚度、板层结构、弹性板层数量、弹性纤维波纹度和组织以及内侧退变特征。使用Krippendorff的alpha来评估观察者间的一致性。与TA相比,AS具有更薄的介质和片层,更多的编织片层结构,更大的弹性纤维波浪形和非平行组织。后TA弹性椎板数目多于AS (p < 0.0001)。除了左侧和后部AS的板层结构外,病理一致性中等至令人满意。在年龄、性别或体重指数高达49 kg/m2的测量中,没有观察到显著差异。这些结果提供了AS的第一个系统组织学概况,并突出了与ta的关键差异,其中一些与退行性变化重叠。认识到这些正常的区域差异对于避免诊断过度和不必要的干预至关重要。准确的标本标记、定位和取样对主动脉病理评估至关重要。
{"title":"Variable regional histomorphology of the ascending aorta: Implications for disease classification","authors":"Collin S. Pryma ,&nbsp;Md. Shahrier Amin ,&nbsp;Charles Leduc ,&nbsp;Cecilia Wu ,&nbsp;Sarah M. Jenkins ,&nbsp;Melanie C. Bois ,&nbsp;Joseph J. Maleszewski","doi":"10.1016/j.carpath.2025.107787","DOIUrl":"10.1016/j.carpath.2025.107787","url":null,"abstract":"<div><div>Regional differences in the normal histology of the ascending aorta have not been systematically studied, possibly resulting in diagnostic misinterpretation. This study aims to characterize the normal histologic spectrum of the aortic sinus (AS) and tubular aorta (TA) in a normal population. Ascending aortic specimens from 37 autopsy cases (mean age 58.7 years, range 12 to &gt;89 years) without known aortopathy were collected prospectively. Transverse and longitudinal sections from AS and TA were stained with H&amp;E and Verhoeff–Van Gieson. Assessed features included medial and lamellar thickness, lamellar architecture, elastic lamina number, elastic fiber waviness and organization, and features of medial degeneration. Interobserver agreement was assessed using Krippendorff’s alpha. The AS had significantly thinner media and lamellae, more woven lamellar architecture, and greater elastic fiber waviness and non-parallel organization compared to the TA. Elastic lamina number was greater in the posterior TA than AS (p &lt; 0.0001). Pathologist agreement was moderate to satisfactory except for lamellar architecture in the left and posterior AS. No significant differences were observed between the measures with age, sex, or body mass index up to 49 kg/m<sup>2</sup>. These results provide the first systematic histologic profile of the AS and highlight key differences from the TA—several of which overlap with degenerative changes. Recognizing these normal regional variations is essential to avoid diagnostic overcalls and unnecessary intervention. Accurate specimen labeling, orientation, and sampling are critical in aortic pathology assessment.</div></div>","PeriodicalId":9451,"journal":{"name":"Cardiovascular Pathology","volume":"80 ","pages":"Article 107787"},"PeriodicalIF":1.9,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145263661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thoracic aortic diseases: Identification of diagnostic biomarkers using proteomic analysis 胸主动脉疾病:用蛋白质组学分析鉴定诊断性生物标志物。
IF 1.9 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-07 DOI: 10.1016/j.carpath.2025.107785
Nico Arndt , Thomas Mair , Maria Riedner , Ali Biabani , Hannah Voß , Hartmut Schlüter , Lukas Förster , Tim Knochenhauer , Marco Sachse , Martin Beyer , Maya Leonhardt , Yskert von Kodolitsch , Christian Schlein , Guido Sauter , Theresa Nauth , Shiho Naito , Evaldas Girdauskas , Hermann Reichenspurner , Christian Detter , Georg Rosenberger , Till Joscha Demal

Introduction

: Thoracic aortic aneurysms frequently go undetected until serious complications like acute dissections or ruptures arise. Therefore, this study aims to identify potential blood circulating biomarkers enabling an easy and early diagnosis of thoracic aortic disease.

Methods

: Potential biomarker candidates were identified through two different techniques, untargeted and targeted proteomic as well as extracellular vesicle (EV) analyses. The biomarker levels were compared between two patient groups with thoracic aortic aneurysms and two control groups without thoracic aortic disease. In total, 80 patients (TAA group (n = 40) vs. control group (n = 40)) were matched for untargeted and targeted proteome analysis, and 85 for EV analysis (TAA group (n = 42) vs. control group (n = 43)), based on the availability of blood samples and excised aortic tissue. Levels of biomarker candidates were correlated with aortic diameter, patient age, and histological alterations in aortic tissue using linear and logistic regression models.

Results

: The untargeted proteomic and EV analysis identified 1,037 and 1,077 proteins, respectively, of which 11 and 28 proteins showed significant differences in concentration between the study groups. Of these, 9 proteins correlated with the aortic diameter: ACTN1 (Regression coefficient B = 1.633, p < 0.001), CRP (B = 0.001, p = 0.004), TGM3 (B=-0.293, p = 0.010), KRT84 (B=-0.477, p = 0.010), IGHG3 (-0.267, p = 0.018), DPYSL2 (B = 0.644, p = 0.020), TSPAN8 (B-0.838, p = 0.042), IGKV3D-11 (B=-0.242, p = 0.046), and VDAC1 (B=-0.491, p = 0.047). Moreover, IGKV3D-11 (B=-3.257, p = 0.029), IGHG3 (B=-0.003, p = 0.034), and APOC3 (B=-2.104, p = 0.037) showed significant correlations with the grade of aortic medial layer degeneration. None of the proteins correlated with patient age.

Conclusion

: The study identified 9 biomarker candidates correlating with the aortic diameter. To enable the clinical use for diagnosis and prognostic assessment, these biomarkers need to be validated in larger external cohorts.
引言:胸主动脉瘤通常不被发现,直到出现严重的并发症,如急性夹层或破裂。因此,本研究旨在确定潜在的血液循环生物标志物,使胸主动脉疾病的早期诊断变得容易。方法:通过两种不同的技术,非靶向和靶向蛋白质组学以及细胞外囊泡(EV)分析,鉴定潜在的生物标志物候选物。比较两组胸主动脉瘤患者和两组无胸主动脉瘤疾病的对照组的生物标志物水平。根据血液样本和切除主动脉组织的可用性,总共有80例患者(TAA组(n=40)对对照组(n=40))进行了非靶向和靶向蛋白质组分析,85例患者(TAA组(n=42)对对照组(n=43))进行了EV分析。使用线性和逻辑回归模型,候选生物标志物水平与主动脉直径、患者年龄和主动脉组织组织学改变相关。结果:非靶向蛋白质组学和EV分析分别鉴定出1037种和1077种蛋白质,其中11种和28种蛋白质在研究组之间的浓度存在显著差异。其中,9种蛋白与主动脉内径相关:ACTN1(回归系数B=1.633, p)。结论:本研究确定了9种与主动脉内径相关的候选生物标志物。为了使临床应用于诊断和预后评估,这些生物标志物需要在更大的外部队列中进行验证。
{"title":"Thoracic aortic diseases: Identification of diagnostic biomarkers using proteomic analysis","authors":"Nico Arndt ,&nbsp;Thomas Mair ,&nbsp;Maria Riedner ,&nbsp;Ali Biabani ,&nbsp;Hannah Voß ,&nbsp;Hartmut Schlüter ,&nbsp;Lukas Förster ,&nbsp;Tim Knochenhauer ,&nbsp;Marco Sachse ,&nbsp;Martin Beyer ,&nbsp;Maya Leonhardt ,&nbsp;Yskert von Kodolitsch ,&nbsp;Christian Schlein ,&nbsp;Guido Sauter ,&nbsp;Theresa Nauth ,&nbsp;Shiho Naito ,&nbsp;Evaldas Girdauskas ,&nbsp;Hermann Reichenspurner ,&nbsp;Christian Detter ,&nbsp;Georg Rosenberger ,&nbsp;Till Joscha Demal","doi":"10.1016/j.carpath.2025.107785","DOIUrl":"10.1016/j.carpath.2025.107785","url":null,"abstract":"<div><h3>Introduction</h3><div><strong>:</strong> Thoracic aortic aneurysms frequently go undetected until serious complications like acute dissections or ruptures arise. Therefore, this study aims to identify potential blood circulating biomarkers enabling an easy and early diagnosis of thoracic aortic disease.</div></div><div><h3>Methods</h3><div><strong>:</strong> Potential biomarker candidates were identified through two different techniques, untargeted and targeted proteomic as well as extracellular vesicle (EV) analyses. The biomarker levels were compared between two patient groups with thoracic aortic aneurysms and two control groups without thoracic aortic disease. In total, 80 patients (TAA group (<em>n</em> = 40) vs. control group (<em>n</em> = 40)) were matched for untargeted and targeted proteome analysis, and 85 for EV analysis (TAA group (<em>n</em> = 42) vs. control group (<em>n</em> = 43)), based on the availability of blood samples and excised aortic tissue. Levels of biomarker candidates were correlated with aortic diameter, patient age, and histological alterations in aortic tissue using linear and logistic regression models.</div></div><div><h3>Results</h3><div><strong>:</strong> The untargeted proteomic and EV analysis identified 1,037 and 1,077 proteins, respectively, of which 11 and 28 proteins showed significant differences in concentration between the study groups. Of these, 9 proteins correlated with the aortic diameter: ACTN1 (Regression coefficient <em>B</em> = 1.633, <em>p</em> &lt; 0.001), CRP (<em>B</em> = 0.001, <em>p</em> = 0.004), TGM3 (<em>B</em>=-0.293, <em>p</em> = 0.010), KRT84 (<em>B</em>=-0.477, <em>p</em> = 0.010), IGHG3 (-0.267, <em>p</em> = 0.018), DPYSL2 (<em>B</em> = 0.644, <em>p</em> = 0.020), TSPAN8 (B-0.838, <em>p</em> = 0.042), IGKV3D-11 (<em>B</em>=-0.242, <em>p</em> = 0.046), and VDAC1 (<em>B</em>=-0.491, <em>p</em> = 0.047). Moreover, IGKV3D-11 (<em>B</em>=-3.257, <em>p</em> = 0.029), IGHG3 (<em>B</em>=-0.003, <em>p</em> = 0.034), and APOC3 (<em>B</em>=-2.104, <em>p</em> = 0.037) showed significant correlations with the grade of aortic medial layer degeneration. None of the proteins correlated with patient age.</div></div><div><h3>Conclusion</h3><div><strong>:</strong> The study identified 9 biomarker candidates correlating with the aortic diameter. To enable the clinical use for diagnosis and prognostic assessment, these biomarkers need to be validated in larger external cohorts.</div></div>","PeriodicalId":9451,"journal":{"name":"Cardiovascular Pathology","volume":"80 ","pages":"Article 107785"},"PeriodicalIF":1.9,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145249875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The orphan receptor GPRC5B promotes macrophage infiltration and an inflammatory plaque phenotype in atherosclerosis 孤儿受体GPRC5B在动脉粥样硬化中促进巨噬细胞浸润和炎症斑块表型。
IF 1.9 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-01 DOI: 10.1016/j.carpath.2025.107784
Greta Verena Freundt , Friedrich Alexander von Samson-Himmelstjerna , Jan-Thorge Nitz , Frederik Stelter , Norbert Frey , Mark Luedde , Michael R. Preusch , Hans-Jörg Hippe

Background and aims

Atherosclerosis is driven by chronic inflammation of the vascular wall, in which macrophages play a central role. The orphan G protein-coupled receptor GPRC5B is expressed in vascular cells and macrophages and is upregulated during monocyte-to-macrophage differentiation. It has been shown to activate NFκB-dependent inflammatory pathways in adipose tissue and glomeruli. Here, we investigated the impact of GPRC5B on macrophage infiltration and the progression of atherosclerotic plaque development in vivo.

Methods

Bone marrow from heterozygous GPRC5B-transgenic C57BL/6 mice and wild-type controls was transplanted into lethally irradiated LDL receptor-deficient mice. Animals were fed a Western-type diet for 16 weeks, after which atherosclerotic lesions in the aortic sinus were analyzed.

Results

Mice receiving GPRC5B-transgenic bone marrow showed no significant differences in serum lipids or cardiac mass indices. However, they exhibited significantly increased macrophage infiltration within atherosclerotic plaques and a non-significant trend toward larger and more complex lesions.

Conclusions

GPRC5B overexpression in bone marrow-derived monocyte/macrophage lineage cells promotes a more inflammatory plaque phenotype, characterized by enhanced macrophage infiltration. These findings highlight GPRC5B as a potential modulator of plaque progression and suggest it may represent a novel therapeutic target in vascular inflammation and atherosclerosis.
背景和目的:动脉粥样硬化是由血管壁的慢性炎症驱动的,其中巨噬细胞起核心作用。孤儿G蛋白偶联受体GPRC5B在血管细胞和巨噬细胞中表达,并在单核细胞向巨噬细胞分化过程中上调。它已被证明可以激活脂肪组织和肾小球中nfκ b依赖的炎症途径。在这里,我们研究了GPRC5B对巨噬细胞浸润和体内动脉粥样硬化斑块发展进程的影响。方法:将杂合gprc5b转基因C57BL/6小鼠和野生型对照小鼠的骨髓移植到低密度脂蛋白受体缺陷小鼠体内。饲喂西式饮食16周,观察主动脉窦动脉粥样硬化病变情况。结果:接受gprc5b转基因骨髓的小鼠血脂和心脏质量指数无显著差异。然而,他们在动脉粥样硬化斑块内表现出明显增加的巨噬细胞浸润,并没有向更大更复杂的病变发展的明显趋势。结论:GPRC5B在骨髓来源的单核细胞/巨噬细胞谱系细胞中的过表达促进了更炎性的斑块表型,其特征是巨噬细胞浸润增强。这些发现强调了GPRC5B作为斑块进展的潜在调节剂,并表明它可能代表血管炎症和动脉粥样硬化的新治疗靶点。
{"title":"The orphan receptor GPRC5B promotes macrophage infiltration and an inflammatory plaque phenotype in atherosclerosis","authors":"Greta Verena Freundt ,&nbsp;Friedrich Alexander von Samson-Himmelstjerna ,&nbsp;Jan-Thorge Nitz ,&nbsp;Frederik Stelter ,&nbsp;Norbert Frey ,&nbsp;Mark Luedde ,&nbsp;Michael R. Preusch ,&nbsp;Hans-Jörg Hippe","doi":"10.1016/j.carpath.2025.107784","DOIUrl":"10.1016/j.carpath.2025.107784","url":null,"abstract":"<div><h3>Background and aims</h3><div>Atherosclerosis is driven by chronic inflammation of the vascular wall, in which macrophages play a central role. The orphan G protein-coupled receptor GPRC5B is expressed in vascular cells and macrophages and is upregulated during monocyte-to-macrophage differentiation. It has been shown to activate NFκB-dependent inflammatory pathways in adipose tissue and glomeruli. Here, we investigated the impact of GPRC5B on macrophage infiltration and the progression of atherosclerotic plaque development in vivo.</div></div><div><h3>Methods</h3><div>Bone marrow from heterozygous GPRC5B-transgenic C57BL/6 mice and wild-type controls was transplanted into lethally irradiated LDL receptor-deficient mice. Animals were fed a Western-type diet for 16 weeks, after which atherosclerotic lesions in the aortic sinus were analyzed.</div></div><div><h3>Results</h3><div>Mice receiving GPRC5B-transgenic bone marrow showed no significant differences in serum lipids or cardiac mass indices. However, they exhibited significantly increased macrophage infiltration within atherosclerotic plaques and a non-significant trend toward larger and more complex lesions.</div></div><div><h3>Conclusions</h3><div>GPRC5B overexpression in bone marrow-derived monocyte/macrophage lineage cells promotes a more inflammatory plaque phenotype, characterized by enhanced macrophage infiltration. These findings highlight GPRC5B as a potential modulator of plaque progression and suggest it may represent a novel therapeutic target in vascular inflammation and atherosclerosis.</div></div>","PeriodicalId":9451,"journal":{"name":"Cardiovascular Pathology","volume":"80 ","pages":"Article 107784"},"PeriodicalIF":1.9,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145225173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical significance of C4d positivity within the first month after heart transplantation in detecting antibody-mediated rejection on endomyocardial biopsies 心脏移植术后1个月内C4d阳性检测心内膜活检抗体介导排斥反应的临床意义。
IF 1.9 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-09-20 DOI: 10.1016/j.carpath.2025.107783
Mengxue Zhang , Yan Zhou , Chrystalle Katte Carreon , Ann Nguyen , Tiana Riley , Aliya N. Husain , Huihua Li

Background

The pathologic definition for antibody-mediated rejection (AMR) includes both histopathological and immunopathological components. C4d is the most validated diagnostic marker for immunopathologic AMR; however, the clinical significance of early C4d positivity (≤1 month post-transplant) on endomyocardial biopsies (EMBs) is unknown.

Methods

Patients who had ≥1 episode of C4d-positive EMB within the first month after heart transplantation were selected, the coexistence with acute cellular rejection (ACR) and the correlations of C4d positivity with histopathologic features of AMR, clinical graft dysfunction, presence of donor specific antibodies (DSAs), and clinical outcomes were examined.

Results

112 EMBs from 46 patients were qualified and included in the study. 19 patients had single C4d-positive EMB whereas 27 patients developed multiple (2-4) episodes of C4d positivity within the first month. 40 % of C4d-positive EMBs showed concurrent ACR (26 with G1R, 6 with G2R). The C4d positivity correlated well with the histopathologic AMR, with 73 % of C4d-positive EMBs showing all or partial histologic features of AMR. Only 29 % of the C4d-positive EMBs were associated with clinical graft dysfunction, indicating that most early C4d-positive EMBs were clinically asymptomatic. DSAs were found positive in 28 patients (61 %), with preformed DSAs being more common than de novo DSAs. Although no cardiac allograft vasculopathy was observed in any patient, two pediatric patients died of AMR shortly after transplantation whereas three adult patients passed away mostly because of infection.

Conclusion

Heart transplant recipients with C4d-positive EMBs within the first month post-transplant were mainly asymptomatic; combined evaluation including clinical, pathological, and serological testing should be conducted for the best management of AMR.
背景:抗体介导的排斥反应(AMR)的病理定义包括组织病理学和免疫病理学两部分。C4d是最有效的免疫病理AMR诊断标志物;然而,早期C4d阳性(移植后≤1个月)在心内膜肌活检(EMBs)中的临床意义尚不清楚。方法:选取心脏移植术后1个月内C4d阳性EMB发作≥1次的患者,观察其是否伴有急性细胞排斥反应(ACR), C4d阳性与AMR的组织病理学特征、临床移植物功能障碍、供体特异性抗体(dsa)的存在及临床结局的相关性。结果:46例患者的112例EMBs合格并纳入研究。19例患者为单一C4d阳性EMB,而27例患者在第一个月内出现多次(2-4次)C4d阳性发作。40%的c4d阳性EMBs并发ACR(26例G1R, 6例G2R)。C4d阳性与组织病理AMR相关,73%的C4d阳性EMBs表现出AMR的全部或部分组织学特征。只有29%的c4d阳性EMBs与临床移植物功能障碍相关,这表明大多数早期c4d阳性EMBs临床无症状。28例患者(61%)发现dsa阳性,预形成的dsa比新生dsa更常见。虽然没有观察到任何患者出现同种异体心脏移植血管病变,但有2例儿童患者在移植后不久死于AMR,而3例成人患者主要死于感染。结论:移植后1个月内c4d阳性EMBs心脏受者以临床无症状为主,应综合考虑临床、病理、血清学评价,以最佳处理AMR。
{"title":"Clinical significance of C4d positivity within the first month after heart transplantation in detecting antibody-mediated rejection on endomyocardial biopsies","authors":"Mengxue Zhang ,&nbsp;Yan Zhou ,&nbsp;Chrystalle Katte Carreon ,&nbsp;Ann Nguyen ,&nbsp;Tiana Riley ,&nbsp;Aliya N. Husain ,&nbsp;Huihua Li","doi":"10.1016/j.carpath.2025.107783","DOIUrl":"10.1016/j.carpath.2025.107783","url":null,"abstract":"<div><h3>Background</h3><div>The pathologic definition for antibody-mediated rejection (AMR) includes both histopathological and immunopathological components. C4d is the most validated diagnostic marker for immunopathologic AMR; however, the clinical significance of early C4d positivity (≤1 month post-transplant) on endomyocardial biopsies (EMBs) is unknown.</div></div><div><h3>Methods</h3><div>Patients who had ≥1 episode of C4d-positive EMB within the first month after heart transplantation were selected, the coexistence with acute cellular rejection (ACR) and the correlations of C4d positivity with histopathologic features of AMR, clinical graft dysfunction, presence of donor specific antibodies (DSAs), and clinical outcomes were examined.</div></div><div><h3>Results</h3><div>112 EMBs from 46 patients were qualified and included in the study. 19 patients had single C4d-positive EMB whereas 27 patients developed multiple (2-4) episodes of C4d positivity within the first month. 40 % of C4d-positive EMBs showed concurrent ACR (26 with G1R, 6 with G2R). The C4d positivity correlated well with the histopathologic AMR, with 73 % of C4d-positive EMBs showing all or partial histologic features of AMR. Only 29 % of the C4d-positive EMBs were associated with clinical graft dysfunction, indicating that most early C4d-positive EMBs were clinically asymptomatic. DSAs were found positive in 28 patients (61 %), with preformed DSAs being more common than de novo DSAs. Although no cardiac allograft vasculopathy was observed in any patient, two pediatric patients died of AMR shortly after transplantation whereas three adult patients passed away mostly because of infection.</div></div><div><h3>Conclusion</h3><div>Heart transplant recipients with C4d-positive EMBs within the first month post-transplant were mainly asymptomatic; combined evaluation including clinical, pathological, and serological testing should be conducted for the best management of AMR.</div></div>","PeriodicalId":9451,"journal":{"name":"Cardiovascular Pathology","volume":"80 ","pages":"Article 107783"},"PeriodicalIF":1.9,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145124274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Giovanni Maria Lancisi (1654-1720) and the first historical investigation on pathology of sudden death 乔瓦尼·玛丽亚·兰西西(1654-1720)和猝死病理学的第一次历史调查。
IF 1.9 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-09-19 DOI: 10.1016/j.carpath.2025.107780
Daniela Marrone , Cristina Basso , Gaetano Thiene
Between 1705 and 1706, Rome experienced a series of sudden deaths, prompting Pope Clement XI to set up a commission to investigate the causes. Giovanni Maria Lancisi, a prominent physician, oversaw forensic autopsies and wrote “De subitaneis mortibus” (“On Sudden Deaths”, 1708), a groundbreaking treatise that examined death through a mechanistic lens, offering both theoretical and practical insights. Lancisi’s book presented life as a dynamic interaction of bodily fluids and systems, with death defined as the cessation of these movements. He proposed that sudden death is not rare but a natural endpoint when life-sustaining processes abruptly cease. The treatise identified various causes of sudden death, involving heart and vessels, and debunked fears of an ongoing epidemic in Rome. By analyzing cadaveric lesions, Lancisi demonstrated that these deaths were primarily due to pre-existing morbid conditions. His observations advanced the emerging field of pathological anatomy, applying scientific method on the study of sudden death.
1705年至1706年间,罗马经历了一系列的突发死亡事件,促使教皇克莱门特十一世成立了一个委员会来调查原因。著名医生乔瓦尼·玛丽亚·兰西西(Giovanni Maria Lancisi)监督法医尸检,并撰写了《猝死论》(De subitaneis mortibus, 1708),这是一部开创性的论文,从机械的角度审视死亡,提供了理论和实践的见解。兰西西的书将生命描述为体液和身体系统的动态相互作用,死亡被定义为这些运动的停止。他提出,猝死并不罕见,而是维持生命的过程突然停止时的自然终点。这篇论文指出了猝死的各种原因,涉及心脏和血管,并揭穿了对罗马正在流行的流行病的恐惧。通过对尸体病变的分析,Lancisi证明这些死亡主要是由于先前存在的病态状况。他的观察促进了病理解剖学这一新兴领域的发展,将科学的方法应用于猝死的研究。
{"title":"Giovanni Maria Lancisi (1654-1720) and the first historical investigation on pathology of sudden death","authors":"Daniela Marrone ,&nbsp;Cristina Basso ,&nbsp;Gaetano Thiene","doi":"10.1016/j.carpath.2025.107780","DOIUrl":"10.1016/j.carpath.2025.107780","url":null,"abstract":"<div><div>Between 1705 and 1706, Rome experienced a series of sudden deaths, prompting Pope Clement XI to set up a commission to investigate the causes. Giovanni Maria Lancisi, a prominent physician, oversaw forensic autopsies and wrote “De subitaneis mortibus” (“On Sudden Deaths”, 1708), a groundbreaking treatise that examined death through a mechanistic lens, offering both theoretical and practical insights. Lancisi’s book presented life as a dynamic interaction of bodily fluids and systems, with death defined as the cessation of these movements. He proposed that sudden death is not rare but a natural endpoint when life-sustaining processes abruptly cease. The treatise identified various causes of sudden death, involving heart and vessels, and debunked fears of an ongoing epidemic in Rome. By analyzing cadaveric lesions, Lancisi demonstrated that these deaths were primarily due to pre-existing morbid conditions. His observations advanced the emerging field of pathological anatomy, applying scientific method on the study of sudden death.</div></div>","PeriodicalId":9451,"journal":{"name":"Cardiovascular Pathology","volume":"80 ","pages":"Article 107780"},"PeriodicalIF":1.9,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145112016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aortic regurgitation as a cause of sudden cardiac death with aortic and left ventricular remodelling - the role of the bicuspid valve 主动脉反流是心源性猝死伴主动脉和左心室重构的原因之一——二尖瓣的作用
IF 1.9 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-09-18 DOI: 10.1016/j.carpath.2025.107781
Lauren Moran, Joseph Westaby, Mary N. Sheppard

Background and objective

Aortic regurgitation (AR) results in blood flow from the aorta back into the left ventricle, which leads to left ventricular hypertrophy and dilation which, in a clinical setting, leads to heart failure and death. However, it is not a well-recognised cause of sudden cardiac death (SCD).

Methods

We identified 10 cases of AR with no other cause of death from our database of 8,551 cases of SCD. All these cases had a full autopsy with negative toxicology. Diagnosis of AR was based upon the presence of prominent ridges on the edge of the aortic valve (AV) cusps with aortic root dilatation, and no significant calcification within the cusps. We measured heart weight, circumference of aortic annulus and ascending aorta, diameter of left ventricle, and circumferential left ventricle wall thickness prospectively. Cases were age and sex matched 2:1 to individuals with morphologically normal hearts with normal aortic valves.

Results

Age was 43±14 years, with 7 males and 3 females in the AR group, and 14 males and 6 females in the control group. Heart weight was significantly higher in individuals with AR compared to controls (642±200g vs 370±75g, p<0.001). All cases showed thick regurgitant ridges on the edges of all valvular leaflets macroscopically. The aortic annulus circumference (73±14mm vs 54±7mm, p<0.001) and the circumference of the ascending aorta (85±27mm vs 56±7mm, p<0.001) were significantly dilated in AR. The left ventricular cavity diameter was significantly larger in AR (52±15mm vs 30±8mm, p<0.001). There was no significant difference seen in maximal wall thickness of the left ventricle (16±6mm vs 14±2mm, p=0.068). 7 out of 10 AR cases had bicuspid aortic valves (70%) while two were rheumatic and one just had a dilated aorta. Microscopically, left ventricular fibrosis was seen in 7 of the AR cases (70%).

Discussion

AR is a rare cause of SCD, most commonly associated with bicuspid aortic valve. It can be recognised by prominent ridges on the AV cusps and/or thickening of the cusp free margin with aortic annular dilatation. It is only considered significant as a cause of death when found with increased heart weight, left ventricular dilatation, and/or ventricular fibrosis in the absence of other cardiac pathology. We demonstrate that there is a strong association between BAV, AR and SCD. As BAV is a congenital condition, clinical or surgical intervention could potentially prevent subsequent cardiac enlargement and fibrosis, thereby preventing SCD.
背景和目的:主动脉反流(AR)导致血液从主动脉流回左心室,导致左心室肥厚和扩张,在临床环境中,导致心力衰竭和死亡。然而,它不是一个公认的心源性猝死(SCD)的原因。方法:我们从8,551例SCD的数据库中确定了10例无其他死因的AR。所有这些病例都经过了完整的尸检毒理学检测呈阴性。诊断AR的依据是主动脉瓣(AV)瓣尖边缘出现突出的隆起,主动脉根部扩张,瓣尖内无明显钙化。我们前瞻性地测量了心脏重量、主动脉环和升主动脉周长、左心室直径和左心室周壁厚度。病例的年龄和性别与形态学正常的心脏和主动脉瓣正常的个体匹配2:1。结果:年龄43±14岁,AR组男性7人,女性3人,对照组男性14人,女性6人。AR患者的心脏重量明显高于对照组(642±200g vs 370±75g)。讨论:AR是SCD的罕见病因,最常与二尖瓣主动脉瓣相关。它可以通过房室尖上突出的隆起和/或无尖缘增厚伴主动脉环扩张来识别。只有在没有其他心脏病理的情况下,伴有心脏重量增加、左心室扩张和/或心室纤维化时,才被认为是重要的死亡原因。我们证明了BAV、AR和SCD之间有很强的相关性。由于BAV是一种先天性疾病,临床或手术干预可以潜在地预防随后的心脏扩大和纤维化,从而预防SCD。
{"title":"Aortic regurgitation as a cause of sudden cardiac death with aortic and left ventricular remodelling - the role of the bicuspid valve","authors":"Lauren Moran,&nbsp;Joseph Westaby,&nbsp;Mary N. Sheppard","doi":"10.1016/j.carpath.2025.107781","DOIUrl":"10.1016/j.carpath.2025.107781","url":null,"abstract":"<div><h3>Background and objective</h3><div>Aortic regurgitation (AR) results in blood flow from the aorta back into the left ventricle, which leads to left ventricular hypertrophy and dilation which, in a clinical setting, leads to heart failure and death. However, it is not a well-recognised cause of sudden cardiac death (SCD).</div></div><div><h3>Methods</h3><div>We identified 10 cases of AR with no other cause of death from our database of 8,551 cases of SCD. All these cases had a full autopsy with negative toxicology. Diagnosis of AR was based upon the presence of prominent ridges on the edge of the aortic valve (AV) cusps with aortic root dilatation, and no significant calcification within the cusps. We measured heart weight, circumference of aortic annulus and ascending aorta, diameter of left ventricle, and circumferential left ventricle wall thickness prospectively. Cases were age and sex matched 2:1 to individuals with morphologically normal hearts with normal aortic valves.</div></div><div><h3>Results</h3><div>Age was 43±14 years, with 7 males and 3 females in the AR group, and 14 males and 6 females in the control group. Heart weight was significantly higher in individuals with AR compared to controls (642±200g vs 370±75g, p&lt;0.001). All cases showed thick regurgitant ridges on the edges of all valvular leaflets macroscopically. The aortic annulus circumference (73±14mm vs 54±7mm, p&lt;0.001) and the circumference of the ascending aorta (85±27mm vs 56±7mm, p&lt;0.001) were significantly dilated in AR. The left ventricular cavity diameter was significantly larger in AR (52±15mm vs 30±8mm, p&lt;0.001). There was no significant difference seen in maximal wall thickness of the left ventricle (16±6mm vs 14±2mm, p=0.068). 7 out of 10 AR cases had bicuspid aortic valves (70%) while two were rheumatic and one just had a dilated aorta. Microscopically, left ventricular fibrosis was seen in 7 of the AR cases (70%).</div></div><div><h3>Discussion</h3><div>AR is a rare cause of SCD, most commonly associated with bicuspid aortic valve. It can be recognised by prominent ridges on the AV cusps and/or thickening of the cusp free margin with aortic annular dilatation. It is only considered significant as a cause of death when found with increased heart weight, left ventricular dilatation, and/or ventricular fibrosis in the absence of other cardiac pathology. We demonstrate that there is a strong association between BAV, AR and SCD. As BAV is a congenital condition, clinical or surgical intervention could potentially prevent subsequent cardiac enlargement and fibrosis, thereby preventing SCD.</div></div>","PeriodicalId":9451,"journal":{"name":"Cardiovascular Pathology","volume":"80 ","pages":"Article 107781"},"PeriodicalIF":1.9,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145102646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aortic valve morphology rather than aortic valve function, aortic dilatation, and age interferes with ascending aortic structural and biomechanical properties 主动脉瓣形态而不是主动脉瓣功能、主动脉扩张和年龄影响升主动脉结构和生物力学特性。
IF 1.9 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-09-18 DOI: 10.1016/j.carpath.2025.107782
Jan M. Federspiel , Jan-Christian Reil , Peter H. Schmidt , Paul Teping , Frank Ramsthaler , Tanja Schwab , Hans-Joachim Schäfers
Aortic valve (AV) malformation and AV malfunction have been linked to aortic wall degeneration. Studies concomitantly assessing AV morphology, AV function, age, ascending aortic dilatation, and aortic biomechanical properties are lacking. This exploratory study aims to close this gap. Surgical samples of the ascending aorta (n=102) were histologically assessed. Based on echocardiographic studies, the elastic modulus (slope stress-strain curve) was calculated. Patient characteristics were collected from the patient charts. Samples obtained during autopsy (n=10) served as reference for the microscopic analysis. The patient characteristics, structural aortic wall changes, and biomechanical wall properties were statistically explored using comparative analyses and a Spearman correlation matrix. Marked medial degeneration was found significantly earlier in life for unicuspid AV morphology compared to bicuspid and tricuspid AV. Significantly fewer lamellar units and thinner aortic walls were found in surgical samples compared to the reference group regardless of AV morphology, AV function, age, and aortic dilatation. Adventitial structural impairment was associated with stiffer aortic walls. Hints were found that AV morphology (rather than AV function, age, and presence/absence of aortic dilatation) affects structural and functional ascending aortic wall properties. Additionally, the observations suggest more advanced aortic degeneration in association with unicuspid AV, underpin the need for non-surgical control samples in surgical pathological studies, and highlight the importance of the adventitial layer for aortic biomechanics.
主动脉瓣畸形和功能障碍与主动脉壁退变有关。同时评估房室形态、房室功能、年龄、升主动脉扩张和主动脉生物力学特性的研究缺乏。本探索性研究旨在缩小这一差距。对102例升主动脉手术标本进行组织学评估。在超声心动图研究的基础上,计算弹性模量(斜率应力-应变曲线)。从患者病历中收集患者特征。尸检中获得的样本(n=10)作为显微镜分析的参考。采用比较分析和Spearman相关矩阵对患者特征、主动脉壁结构改变和生物力学特性进行统计学探讨。与二尖瓣和三尖瓣AV相比,单尖瓣AV形态在生命早期发现明显的内侧退变。与参考组相比,无论AV形态、AV功能、年龄和主动脉扩张情况如何,手术样本中发现的板层单位明显减少,主动脉壁更薄。动脉外结构损伤与主动脉壁硬化有关。我们发现,房颤形态(而不是房颤功能、年龄和是否有主动脉扩张)影响升主动脉壁的结构和功能特性。此外,观察结果表明,与单尖瓣AV相关的晚期主动脉退变更严重,支持了手术病理研究中对非手术对照样本的需求,并强调了主动脉外膜层生物力学的重要性。
{"title":"Aortic valve morphology rather than aortic valve function, aortic dilatation, and age interferes with ascending aortic structural and biomechanical properties","authors":"Jan M. Federspiel ,&nbsp;Jan-Christian Reil ,&nbsp;Peter H. Schmidt ,&nbsp;Paul Teping ,&nbsp;Frank Ramsthaler ,&nbsp;Tanja Schwab ,&nbsp;Hans-Joachim Schäfers","doi":"10.1016/j.carpath.2025.107782","DOIUrl":"10.1016/j.carpath.2025.107782","url":null,"abstract":"<div><div>Aortic valve (AV) malformation and AV malfunction have been linked to aortic wall degeneration. Studies concomitantly assessing AV morphology, AV function, age, ascending aortic dilatation, and aortic biomechanical properties are lacking. This exploratory study aims to close this gap. Surgical samples of the ascending aorta (n=102) were histologically assessed. Based on echocardiographic studies, the elastic modulus (slope stress-strain curve) was calculated. Patient characteristics were collected from the patient charts. Samples obtained during autopsy (n=10) served as reference for the microscopic analysis. The patient characteristics, structural aortic wall changes, and biomechanical wall properties were statistically explored using comparative analyses and a Spearman correlation matrix. Marked medial degeneration was found significantly earlier in life for unicuspid AV morphology compared to bicuspid and tricuspid AV. Significantly fewer lamellar units and thinner aortic walls were found in surgical samples compared to the reference group regardless of AV morphology, AV function, age, and aortic dilatation. Adventitial structural impairment was associated with stiffer aortic walls. Hints were found that AV morphology (rather than AV function, age, and presence/absence of aortic dilatation) affects structural and functional ascending aortic wall properties. Additionally, the observations suggest more advanced aortic degeneration in association with unicuspid AV, underpin the need for non-surgical control samples in surgical pathological studies, and highlight the importance of the adventitial layer for aortic biomechanics.</div></div>","PeriodicalId":9451,"journal":{"name":"Cardiovascular Pathology","volume":"80 ","pages":"Article 107782"},"PeriodicalIF":1.9,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145102644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of amyloid deposition in patients undergoing surgical myectomy for presumed hypertrophic cardiomyopathy 因肥厚性心肌病而行肌切除术的患者中淀粉样蛋白沉积的患病率。
IF 1.9 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-09-11 DOI: 10.1016/j.carpath.2025.107779
David S. Katzianer , Deborah H. Kwon , Maran Thamilarasan , J. Emanuel Finet , Wael Jaber , Milind Desai , Nicholas Smedira , E. Rene Rodriguez , Carmela D. Tan , Mazen Hanna

Background

Cardiac amyloidosis (CA) and hypertrophic cardiomyopathy (HCM) share the phenotypic characteristic of increased left ventricular wall thickness and, while more common with HCM, both conditions can result in dynamic left ventricular outflow (LVOT) obstruction. We sought to examine the incidence of amyloid deposition in myectomy specimens at a high-volume center for surgical myectomy and describe the pathologic characteristics and patient population.

Methods and Results

We reviewed the surgical myectomy database at our institution and found a total of 27 of 3,292 (0.8 %) with cardiac amyloidosis on pathologic examination of myectomy specimens. Many of these had preoperative imaging features consistent with hypertrophic cardiomyopathy with asymmetric hypertrophy and LVOT obstructive physiology.

Conclusion

Nearly 1 % of patients referred for surgical myectomy were found to have unexpected amyloid deposits on pathologic examination. Recognition of this finding, although very infrequent, is important for long-term management of these patients.
背景:心脏淀粉样变性(CA)和肥厚性心肌病(HCM)都具有左心室壁厚度增加的表型特征,虽然在HCM中更为常见,但这两种疾病都可导致动态左心室流出(LVOT)梗阻。我们试图检查淀粉样蛋白沉积的发生率在一个高容量中心的肌瘤切除手术标本,并描述病理特征和患者群体。方法和结果:我们回顾了我院的手术肌瘤切除数据库,在肌瘤切除标本的病理检查中发现3292例中有27例(0.8%)患有心脏淀粉样变性。其中许多患者术前影像学特征符合肥厚性心肌病伴不对称肥厚和左心室血栓梗阻性生理特征。结论:近1%的患者在病理检查中发现了意想不到的淀粉样蛋白沉积。认识到这一发现,虽然非常罕见,但对这些患者的长期管理很重要。
{"title":"Prevalence of amyloid deposition in patients undergoing surgical myectomy for presumed hypertrophic cardiomyopathy","authors":"David S. Katzianer ,&nbsp;Deborah H. Kwon ,&nbsp;Maran Thamilarasan ,&nbsp;J. Emanuel Finet ,&nbsp;Wael Jaber ,&nbsp;Milind Desai ,&nbsp;Nicholas Smedira ,&nbsp;E. Rene Rodriguez ,&nbsp;Carmela D. Tan ,&nbsp;Mazen Hanna","doi":"10.1016/j.carpath.2025.107779","DOIUrl":"10.1016/j.carpath.2025.107779","url":null,"abstract":"<div><h3>Background</h3><div>Cardiac amyloidosis (CA) and hypertrophic cardiomyopathy (HCM) share the phenotypic characteristic of increased left ventricular wall thickness and, while more common with HCM, both conditions can result in dynamic left ventricular outflow (LVOT) obstruction. We sought to examine the incidence of amyloid deposition in myectomy specimens at a high-volume center for surgical myectomy and describe the pathologic characteristics and patient population.</div></div><div><h3>Methods and Results</h3><div>We reviewed the surgical myectomy database at our institution and found a total of 27 of 3,292 (0.8 %) with cardiac amyloidosis on pathologic examination of myectomy specimens. Many of these had preoperative imaging features consistent with hypertrophic cardiomyopathy with asymmetric hypertrophy and LVOT obstructive physiology.</div></div><div><h3>Conclusion</h3><div>Nearly 1 % of patients referred for surgical myectomy were found to have unexpected amyloid deposits on pathologic examination. Recognition of this finding, although very infrequent, is important for long-term management of these patients.</div></div>","PeriodicalId":9451,"journal":{"name":"Cardiovascular Pathology","volume":"80 ","pages":"Article 107779"},"PeriodicalIF":1.9,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145058314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVER 3: Editorial Board 封面3:编辑委员会
IF 1.9 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-09-11 DOI: 10.1016/S1054-8807(25)00058-4
{"title":"COVER 3: Editorial Board","authors":"","doi":"10.1016/S1054-8807(25)00058-4","DOIUrl":"10.1016/S1054-8807(25)00058-4","url":null,"abstract":"","PeriodicalId":9451,"journal":{"name":"Cardiovascular Pathology","volume":"79 ","pages":"Article 107773"},"PeriodicalIF":1.9,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145044400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVER 4: Table of Contents/Barcode PMS 200 封面4:目录/条形码PMS 200
IF 1.9 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-09-11 DOI: 10.1016/S1054-8807(25)00059-6
{"title":"COVER 4: Table of Contents/Barcode PMS 200","authors":"","doi":"10.1016/S1054-8807(25)00059-6","DOIUrl":"10.1016/S1054-8807(25)00059-6","url":null,"abstract":"","PeriodicalId":9451,"journal":{"name":"Cardiovascular Pathology","volume":"79 ","pages":"Article 107774"},"PeriodicalIF":1.9,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145044401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cardiovascular Pathology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1